Chizuko Kanbayashi
Niigata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Comparative Study of Mentorship for Female Surgeons in Japan: Surveys Conducted in 2011 and 2024.
Journal: The Journal of surgical research
Published: December 21, 2025
Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trial.
Journal: British journal of cancer
Published: March 06, 2025
Prefectural Survey on Anthracycline-Related Cardiomyopathy at the Start of the Basic Plan to Promote Cancer Control Programs - Phase 4.
Journal: Circulation reports
Published: January 07, 2025
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community.
Journal: Breast cancer (Tokyo, Japan)
Published: April 19, 2024
Update on the management of ductal carcinoma in situ of the breast: current approach and future perspectives.
Journal: Japanese journal of clinical oncology
Published: April 15, 2024
Clinical features of skin metastasis from breast cancer: A retrospective observational study in Japan.
Journal: The Journal of dermatology
Published: January 27, 2024
Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition.
Journal: Breast cancer (Tokyo, Japan)
Published: December 11, 2023
The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition.
Journal: Breast cancer (Tokyo, Japan)
Published: September 12, 2023
Alopecia neoplastica: A manifestation of metastatic breast cancer.
Journal: Skin health and disease
Published: August 26, 2023
A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer.
Journal: Breast cancer research and treatment
Published: July 06, 2023
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
Journal: Breast cancer research and treatment
Published: July 03, 2023
Last Updated: 09/26/2026